Medanta to operate and manage 750 bed super speciality hospital in Pitampura, New Delhi
Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years
Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years
The new range incorporates a product that also contains the S-PRG filler employed in the Giomer range
The company uses iPS cells to develop treatments for diseases relating to the kidney
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
Partnership to Combine AbbVie's Oncology Expertise with EvolveImmune's Proprietary EVOLVE T-Cell Engager Platform to Develop Novel Multispecific Therapeutic Antibodies for Cancer
CMG1A46 is an investigational T cell-engager with potential to deeply deplete uncontrolled B cells present in autoimmune diseases such as lupus
Union Government will provide a health cover of Rs. 5 lakh to any elderly person above 70 years of age
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
Subscribe To Our Newsletter & Stay Updated